BOLERO-3 Biomarker Study Provides Clues for Response to Everolimus – OncLive
OncLiveBOLERO-3 Biomarker Study Provides Clues for Response to EverolimusOncLiveExploratory analysis of biomarkers in the BOLERO-3 trial suggests that the addition of everolimus to trastuzumab plus vinorelbine for HER2-positive advanced breast cancer m…
